Full text is available at the source.
Abstract
Sodium oxybate, a product of gamma-hydroxybutyrate (GHB), is discussed as a case study for regulatory pathways of Schedule I substances.
- Sodium oxybate is categorized as a Schedule I substance.
- The review highlights regulatory similarities between sodium oxybate and psychedelics.
- Insights from sodium oxybate's regulatory journey may inform approaches for other Schedule I substances.
Simplified
Psychedelic Science